UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Extramammary Paget disease of the vulva: Management and prognosis

Gynecologic oncology, 2020-04, Vol.157 (1), p.146-150

2020

Volltextzugriff (PDF)

Dysregulated transcriptional responses to SARS-CoV-2 in the periphery

Nature communications, 2021-02, Vol.12 (1), p.1079-1079, Article 1079

2021

Volltextzugriff (PDF)

Survival implications of time to surgical treatment of endometrial cancers

American journal of obstetrics and gynecology, 2017-03, Vol.216 (3), p.268.e1-268.e18

2017

Volltextzugriff (PDF)

Ovarian Sertoli-Leydig and granulosa cell tumor: comparison of epidemiology and survival outcomes

Archives of gynecology and obstetrics, 2020-08, Vol.302 (2), p.481-486

2020

Volltextzugriff (PDF)

Oncologic outcomes of minimally invasive versus open radical hysterectomy for early stage cervical carcinoma and tumor size <2 cm: a systematic review and meta-analysis

International journal of gynecological cancer, 2021-07, Vol.31 (7), p.983-990

2021

Volltextzugriff (PDF)

Racial disparities in receipt of radiation and brachytherapy in cervical cancer patients: Do they exist in a SEER-Medicare population?

Gynecologic oncology reports, 2024-10, Vol.55, p.101505, Article 101505

2024

Volltextzugriff (PDF)

Predictive value of 5-Factor modified frailty index in Oncologic and benign hysterectomies

Gynecologic oncology reports, 2022-10, Vol.43, p.101063-101063, Article 101063

2022

Volltextzugriff (PDF)

Robotic versus open radical hysterectomy: A comparative study at a single institution

Gynecologic oncology, 2008-12, Vol.111 (3), p.425-430

2008

Volltextzugriff (PDF)

Prior authorization for FDA-approved PARP inhibitors in ovarian cancer

Gynecologic oncology reports, 2024-04, Vol.52, p.101335, Article 101335

2024

Volltextzugriff (PDF)

The complex triad of obesity, diabetes and race in Type I and II endometrial cancers: Prevalence and prognostic significance

Gynecologic oncology, 2014-04, Vol.133 (1), p.28-32

2014

Volltextzugriff (PDF)

Does tumor grade influence the rate of lymph node metastasis in apparent early stage ovarian cancer?

Archives of gynecology and obstetrics, 2018-07, Vol.298 (1), p.179-182

2018

Volltextzugriff (PDF)

An evaluation of the microbiota of the upper reproductive tract of women with and without epithelial ovarian cancer

Gynecologic oncology reports, 2022-08, Vol.42, p.101017, Article 101017

2022

Volltextzugriff (PDF)

Early-career and fellow gynecologic oncologists perceive underpreparedness for the business of medicine: A Society of gynecologic oncology survey study

Gynecologic oncology reports, 2024-10, Vol.55, p.101501, Article 101501

2024

Volltextzugriff (PDF)

Insurance and racial disparities in prior authorization in gynecologic oncology

Gynecologic oncology reports, 2023-04, Vol.46, p.101159, Article 101159

2023

Volltextzugriff (PDF)

Disparities in cancer-specific and overall survival in black women with endometrial cancer: A Medicare-SEER study

Gynecologic oncology reports, 2022-04, Vol.40, p.100922-100922, Article 100922

2022

Volltextzugriff (PDF)

Implementation of immunotherapy in recurrent endometrial cancer: a real-world cohort study

American journal of obstetrics and gynecology, 2024-11, Vol.231 (5), p.e174-e185

2024

Volltextzugriff (PDF)

Disparities in clinical drug trial participation in endometrial cancer: a real-world analysis

American journal of obstetrics and gynecology, 2024-09

2024

Volltextzugriff (PDF)

Insurance status and time to radiation care after pathologic diagnosis for cervical cancer patients

Gynecologic oncology reports, 2023-06, Vol.47, p.101177-101177, Article 101177

2023

Volltextzugriff (PDF)

Variation in telemedicine usage in gynecologic cancer: Are we widening or narrowing disparities?

Gynecologic oncology, 2024-05, Vol.184, p.160-167

2024

Volltextzugriff (PDF)

Disparities in clinical trial participation in ovarian cancer: A real-world analysis

Gynecologic oncology, 2023-08, Vol.175, p.25-31

2023

Volltextzugriff (PDF)

Disparities in biomarker testing in ovarian cancer: a real-world analysis

American journal of obstetrics and gynecology, 2023-01, Vol.228 (1), p.98-100.e1

2023

Volltextzugriff (PDF)

Patterns of adjuvant treatment and survival outcomes in stage I uterine carcinosarcoma

Gynecologic oncology reports, 2022-02, Vol.39, p.100930-100930, Article 100930

2022

Volltextzugriff (PDF)

Addressing transportation barriers in oncology: existing programs and new solutions

Supportive care in cancer, 2024-05, Vol.32 (5), p.317-317, Article 317

2024

Volltextzugriff (PDF)

“Having cancer is very expensive”: A qualitative study of patients with ovarian cancer and PARP inhibitor treatment

Gynecologic oncology, 2024-07, Vol.186, p.170-175

2024

Volltextzugriff (PDF)

Role of adjuvant chemotherapy in the management of stage IC ovarian granulosa cell tumors

Gynecologic oncology reports, 2019-05, Vol.28, p.145-148

2019

Volltextzugriff (PDF)

1 – 25 von 311

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(290)
Mit Volltextzugriff
(243)

Publikationsform

Sprache

Englisch
(311)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Extramammary Paget disease of the vulva: Management and prognosis

Dysregulated transcriptional responses to SARS-CoV-2 in the periphery

Survival implications of time to surgical treatment of endometrial cancers

Ovarian Sertoli-Leydig and granulosa cell tumor: comparison of epidemiology and survival outcomes

Oncologic outcomes of minimally invasive versus open radical hysterectomy for early stage cervical carcinoma and tumor size <2 cm: a systematic review and meta-analysis

Racial disparities in receipt of radiation and brachytherapy in cervical cancer patients: Do they exist in a SEER-Medicare population?

Predictive value of 5-Factor modified frailty index in Oncologic and benign hysterectomies

Robotic versus open radical hysterectomy: A comparative study at a single institution

Prior authorization for FDA-approved PARP inhibitors in ovarian cancer

The complex triad of obesity, diabetes and race in Type I and II endometrial cancers: Prevalence and prognostic significance

Does tumor grade influence the rate of lymph node metastasis in apparent early stage ovarian cancer?

An evaluation of the microbiota of the upper reproductive tract of women with and without epithelial ovarian cancer

Early-career and fellow gynecologic oncologists perceive underpreparedness for the business of medicine: A Society of gynecologic oncology survey study

Insurance and racial disparities in prior authorization in gynecologic oncology

Disparities in cancer-specific and overall survival in black women with endometrial cancer: A Medicare-SEER study

Implementation of immunotherapy in recurrent endometrial cancer: a real-world cohort study

Disparities in clinical drug trial participation in endometrial cancer: a real-world analysis

Insurance status and time to radiation care after pathologic diagnosis for cervical cancer patients

Variation in telemedicine usage in gynecologic cancer: Are we widening or narrowing disparities?

Disparities in clinical trial participation in ovarian cancer: A real-world analysis

Disparities in biomarker testing in ovarian cancer: a real-world analysis

Patterns of adjuvant treatment and survival outcomes in stage I uterine carcinosarcoma

Addressing transportation barriers in oncology: existing programs and new solutions

“Having cancer is very expensive”: A qualitative study of patients with ovarian cancer and PARP inhibitor treatment

Role of adjuvant chemotherapy in the management of stage IC ovarian granulosa cell tumors

Suchergebnisse filtern